Development of a Plasma Screening Panel for Pediatric Nonalcoholic Fatty Liver Disease Using Metabolomics
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children, but diagnosis is challenging due to limited availability of noninvasive biomarkers. Machine learning applied to high‐resolution metabolomics and clinical phenotype data offers a novel framework for develop...
Main Authors: | Richard D. Khusial, Catherine E. Cioffi, Shelley A. Caltharp, Alyssa M. Krasinskas, Adina Alazraki, Jack Knight‐Scott, Rebecca Cleeton, Eduardo Castillo‐Leon, Dean P. Jones, Bridget Pierpont, Sonia Caprio, Nicola Santoro, Ayman Akil, Miriam B. Vos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-10-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1417 |
Similar Items
-
Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach
by: Ran Jin, et al.
Published: (2020-01-01) -
Perspectives on youth‐onset nonalcoholic fatty liver disease
by: Eduardo Castillo‐Leon, et al.
Published: (2020-10-01) -
Serum metabolomic analysis of the effect of exercise on nonalcoholic fatty liver disease
by: Jia Li, et al.
Published: (2019-03-01) -
Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics
by: Xuyun He, et al.
Published: (2016-03-01) -
Metabolomics Characterizes the Effects and Mechanisms of Quercetin in Nonalcoholic Fatty Liver Disease Development
by: Yan Xu, et al.
Published: (2019-03-01)